Drammen Sykehus

Drammen Sykehus is involved in clinical research on atherosclerotic cardiovascular disease and atrial fibrillation, with studies focused on preventing major heart and stroke events and improving protection against clot-related complications.

• Testing new approaches to reduce the risk of heart attack, stroke, and cardiovascular death
• Evaluating whether anticoagulation can better prevent stroke and systemic embolism in transient atrial fibrillation
• Studying treatment strategies for patients with stress-related atrial fibrillation to improve long-term outcomes

These trials aim to strengthen cardiovascular prevention and refine treatment choices for people at high risk of serious vascular events.

The site is also active in cancer research, especially for breast cancer and pancreatic ductal cancer, where investigators are exploring ways to improve treatment effectiveness and reduce disease progression.

• Assessing new treatment combinations for hormone receptor positive and triple negative breast cancer
• Comparing therapies to improve survival outcomes after breast cancer surgery
• Studying ways to prevent thrombosis in pancreatic cancer patients receiving supportive care

This research reflects a strong interest in both oncology and supportive strategies that may improve patient outcomes and safety.

Clinical trials at Drammen Sykehus include work in multiple sclerosis and acute ischemic stroke, with a focus on treatment safety, symptom control, and better recovery after neurological events.

• Evaluating safety and long-term tolerability of treatments for relapsing multiple sclerosis
• Studying whether new add-on therapy can support disease control in people with multiple sclerosis
• Comparing stroke treatment strategies to improve early neurological recovery

These studies support ongoing progress in neurology, especially for conditions where timely and effective treatment can make a major difference.

Research in rheumatoid arthritis at this hospital focuses on maintaining stable disease control and reducing flare-ups for people living with chronic inflammatory joint disease.

• Testing whether proactive monitoring can improve control of rheumatoid arthritis
• Exploring treatment management strategies for patients receiving biologic therapy

This work is designed to improve everyday care in rheumatology by helping clinicians tailor treatment more effectively.

The site contributes to studies in overweight and obesity, with research aimed at supporting weight reduction and healthier metabolic outcomes alongside lifestyle counseling.

• Evaluating whether a new therapy can help achieve meaningful weight loss
• Comparing weight reduction outcomes against placebo in people with excess body weight

These trials reflect a practical focus on metabolic health and long-term weight management.

Clinical research at the site also includes hearing disorders, particularly idiopathic sudden sensorineural hearing loss, where investigators are examining ways to improve recovery after sudden hearing loss.

• Testing whether an added treatment can improve hearing outcomes
• Comparing recovery results between standard care and supportive therapy

This research aims to improve ear and hearing care by finding better options for patients with sudden auditory loss.